Rationale of the PAPAartis trial

Surgical and interventional repair of thoracoabdominal aortic aneurysms improve survival significantly compared to the natural history of the disease. However, both strategies are associated with a substantial risk of spinal cord ischemia, which has been reported to occur-even in contemporary series by expert centers- in up to 12% of patients, depending on the extent of the disease. Following improved neurological outcomes after staged approaches in extensive clinical and long-term large animal studies, and the description of the collateral network, the concept of Minimally Invasive Staged Segmental Artery Coil Embolization (MIS2ACE) was introduced by Etz et al. This concept of priming the collateral network in order to improve spinal cord blood supply showed promising experimental and early clinical outcomes, and consequently led to the initiation of the randomized controlled multicenter PAPAartis trial (Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging). This Keynote Lecture describes the background and rationale for this trial and gives an update on the current status.

Automated summary

Surgical and interventional repair of thoracoabdominal aortic aneurysms significantly improve survival but carry a risk of spinal cord ischemia. The concept of Minimally Invasive Staged Segmental Artery Coil Embolization (MIS2ACE) shows promise in improving spinal cord blood supply and has led to a randomized controlled multicenter trial.